Keryx Biopharmaceuticals, Inc.New York, NY, United States (NASDAQ (GM): KERX)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Keryx Biopharmaceuticals Financial Forecast

In-Depth Earnings Estimates

Current Quarter
Sep 08
Next Quarter
Feb 08
Current Year
Feb 08
Next Year
Feb 09
Average Estimate ($0.13) ($0.12) ($1.22) ($0.62)
Number of Analysts 4 4 4 4
High Estimate ($0.09) ($0.08) ($1.13) ($0.40)
Low Estimate ($0.16) ($0.16) ($1.27) ($0.83)
Year Ago EPS ($0.45) ($0.67) ($2.07) ($1.22)
Growth Rate 71% 81.72% 41.30% 48.97%
Consensus Recommendation: Hold
Interactive Data

Market Data provided by Interactive Data Managed Solutions.
Earnings Data provided by Zacks.